Fast Five Quiz: Triple-Negative Breast Cancer

Pavani Chalasani, MD, MPH


September 17, 2020

According to the World Health Organization, more than 2 million new cases of breast cancer were diagnosed in 2018, a figure equivalent to the number of new cases of lung cancer. Despite significant advances in care, breast cancer remains a leading cause of cancer death among women around the world. Although it occurs less frequently than other subtypes of breast cancer, triple-negative breast cancer (TNBC) is more commonly diagnosed in younger women and associated with increased rates of early recurrence and mortality compared with other subtypes. Additionally, TNBC has historically been considered a difficult cancer to treat, largely due to its aggressive tumor biology and the paucity of available therapies. Heightened understanding of the biology and pathogenesis of TNBC has resulted in new treatment approaches that have the potential to improve outcomes.

How much do you know about TNBC? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.